Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in FATE — Fate Therapeutics Inc

CIK 1446194 BALA CYNWYD, PA
Back to FATE Full portfolio

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$358,195
+$54,208 QoQ
Shares Held
298,496
-3.8% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Derivatives in FATE

reported options exposure · as of Mar 31, 2026
CallValue
$60,600
CallShares
50,500
PutValue
$37,800
PutShares
31,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. FATE ranks #256 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CYTK
Cytokinetics Inc
 898,951 $59,249,860
2 ALNY
Alnylam Pharmaceuticals, Inc.
 174,268 $57,660,053
3 AGIO
Agios Pharmaceuticals, Inc.
 1,344,953 $45,499,759
4 ABVX
Abivax S.A.
 381,282 $42,455,750
5 BBIO
BridgeBio Pharma, Inc.
 398,943 $29,625,507
6 INSM
INSMED Inc
 173,630 $28,391,977
7 CRSP
CRISPR Therapeutics AG
 593,406 $28,228,323
8 TERN
Terns Pharmaceuticals, Inc.
 521,571 $27,497,223

All Filings in FATE

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $60,600 50,500
2026-03-31 $37,800 31,500
2026-03-31 $358,195 298,496
2025-12-31 $303,987 310,191
2025-12-31 $74,382 75,900
2025-09-30 $225,448 178,927
2025-06-30 $110,096 98,300
2025-06-30 $323,939 289,232
2025-03-31 $140,114 177,360
2024-12-31 $177,233 107,414
2024-12-31 $42,075 25,500
2024-09-30 $198,663 56,761
2024-06-30 $39,032 11,900
2024-06-30 $174,801 53,293
2024-03-31 $286,260 39,000
2024-03-31 $448,474 61,100
2024-03-31 $685,085 93,336
2023-12-31 $570,383 152,509
2023-09-30 $922,479 435,132
2023-06-30 $151,368 31,800
2023-06-30 $2,310,302 485,358
2023-03-31 $58,710 10,300
2023-03-31 $4,971,618 872,214
2022-12-31 $369,465 36,617
2022-12-31 $282,520 28,000
2022-09-30 $273,402 12,200
2022-09-30 $2,829,083 126,242
2022-09-30 $468,369 20,900
2022-06-30 $2,391,270 96,500
2022-06-30 $2,883,202 116,352
2022-06-30 $364,266 14,700
2022-03-31 $1,093,314 28,200
2022-03-31 $1,954,008 50,400
2022-03-31 $2,125,100 54,813
2021-12-31 $6,213,937 106,203
2021-12-31 $1,708,492 29,200
2021-12-31 $2,328,698 39,800
2021-09-30 $8,931,989 150,700
2021-09-30 $2,430,070 41,000
2021-09-30 $5,109,903 86,214
2021-06-30 $5,840,967 67,300
2021-06-30 $2,864,763 33,008
2021-06-30 $6,075,300 70,000
2021-03-31 $3,475,844 42,157
2021-03-31 $9,564,200 116,000
2021-03-31 $9,267,380 112,400
2020-12-31 $4,646,523 51,100
2020-12-31 $6,435,934 70,779
2020-12-31 $5,328,498 58,600
2020-09-30 $5,327,361 133,284

Report a Problem

Category
Description
Email (optional, for follow-up)